Tarassishin et al. found that increased IL-1β processing by upregulated NLRP3 expression in human astrocytes and astrogliomas conferred them a mesenchymal phenotype, including increased migratory capacity, unique gene signature and proinflammatory signaling [35]. This evidence concerns the gene NLRP3 and astrocytic tumor.